| Year |
Citation |
Score |
| 2023 |
Jain AK, Buchannan P, Yates KP, Belt P, Schwimmer JB, Rosenthal P, Murray KF, Molleston JP, Scheimann A, Xanthakos SA, Behling CA, Hertel P, Nilson J, Neuschwander-Tetri BA, Tonascia J, ... Vos MB, et al. Nutrition assessment and MASH severity in children using the Healthy Eating Index. Hepatology Communications. 7. PMID 38055641 DOI: 10.1097/HC9.0000000000000320 |
0.35 |
|
| 2023 |
Huneault HE, Ramirez Tovar A, Sanchez-Torres C, Welsh JA, Vos MB. The Impact and Burden of Dietary Sugars on the Liver. Hepatology Communications. 7. PMID 37930128 DOI: 10.1097/HC9.0000000000000297 |
0.64 |
|
| 2023 |
Wang A, Blackford AL, Behling C, Wilson LA, Newton KP, Xanthakos SA, Fishbein MH, Vos MB, Mouzaki M, Molleston JP, Jain AK, Hertel P, Harlow Adams K, Schwimmer JB. Development of Fibro-PeN, a clinical prediction model for moderate to severe fibrosis in children with nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). PMID 37870272 DOI: 10.1097/HEP.0000000000000644 |
0.349 |
|
| 2023 |
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, ... ... Vos MB, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Annals of Hepatology. 101133. PMID 37364816 DOI: 10.1016/j.aohep.2023.101133 |
0.346 |
|
| 2023 |
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, ... ... Vos MB, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Journal of Hepatology. PMID 37364790 DOI: 10.1016/j.jhep.2023.06.003 |
0.346 |
|
| 2023 |
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, ... ... Vos MB, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology (Baltimore, Md.). PMID 37363821 DOI: 10.1097/HEP.0000000000000520 |
0.346 |
|
| 2023 |
Dybbro E, Vos MB, Kohli R. Special Population: Pediatric Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease. 27: 471-482. PMID 37024219 DOI: 10.1016/j.cld.2023.01.012 |
0.332 |
|
| 2023 |
Cohen CC, Huneault H, Accardi CJ, Jones DP, Liu K, Maner-Smith KM, Song M, Welsh JA, Ugalde-Nicalo PA, Schwimmer JB, Vos MB. Metabolome × Microbiome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys. Metabolites. 13. PMID 36984841 DOI: 10.3390/metabo13030401 |
0.59 |
|
| 2023 |
Kraus EM, Pierce SL, Porter R, Kompaniyets L, Vos MB, Blanck HM, King RJ, Goodman AB. Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease. Childhood Obesity (Print). PMID 36862137 DOI: 10.1089/chi.2022.0208 |
0.343 |
|
| 2022 |
Alkhouri N, Almomani A, Le P, Payne JY, Asaad I, Sakkal C, Vos M, Noureddin M, Kumar P. The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database. Bmc Gastroenterology. 22: 366. PMID 35907827 DOI: 10.1186/s12876-022-02430-7 |
0.412 |
|
| 2022 |
Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, Kashyap S, Mechanick JI, Mouzaki M, Nadolsky K, Rinella ME, Vos MB, Younossi Z. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 28: 528-562. PMID 35569886 DOI: 10.1016/j.eprac.2022.03.010 |
0.303 |
|
| 2022 |
Castillo-Leon E, Morris HL, Schoen C, Bilhartz J, McKiernan P, Miloh T, Palle S, Kabbany MN, Munoz B, Mospan AR, Rudolph B, Xanthakos SA, Vos MB. Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease. Children (Basel, Switzerland). 9. PMID 35327746 DOI: 10.3390/children9030374 |
0.36 |
|
| 2022 |
Westbrook AL, Benedit LC, Frediani JK, Griffiths MA, Khan NY, Levy JM, Morris CR, Rostad CA, Stone CL, Sullivan J, Vos MB, Welsh J, Wood A, Martin GS, Lam W, et al. Predictive value of isolated symptoms for diagnosis of SARS-CoV-2 infection in children tested during peak circulation of the delta variant. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35271694 DOI: 10.1093/cid/ciac112 |
0.473 |
|
| 2022 |
Vos MB, Van Natta ML, Blondet NM, Dasarathy S, Fishbein M, Hertel P, Jain AK, Karpen SJ, Lavine JE, Mohammad S, Miriel LA, Molleston JP, Mouzaki M, Sanyal A, Sharkey EP, et al. Randomized Placebo-Controlled Trial of Losartan for Pediatric Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.). PMID 35133671 DOI: 10.1002/hep.32403 |
0.344 |
|
| 2021 |
Cohen CC, Li KW, Alazraki AL, Beysen C, Carrier CA, Cleeton RL, Dandan M, Figueroa J, Knight-Scott J, Knott CJ, Newton KP, Nyangau EM, Sirlin CB, Ugalde-Nicalo PA, Welsh JA, ... ... Vos MB, et al. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease. The Journal of Clinical Investigation. 131. PMID 34907907 DOI: 10.1172/JCI150996 |
0.639 |
|
| 2021 |
Sekkarie A, Welsh JA, Northstone K, Stein AD, Ramakrishnan U, Vos MB. Associations of maternal diet and nutritional status with offspring hepatic steatosis in the Avon longitudinal study of parents and children. Bmc Nutrition. 7: 28. PMID 34233762 DOI: 10.1186/s40795-021-00433-3 |
0.632 |
|
| 2021 |
Barritt AS, Watkins S, Gitlin N, Klein S, Lok AS, Loomba R, Schoen C, Reddy KR, Trinh HN, Mospan AR, Vos MB, Weiss LM, Cusi K, Neuschwander-Tetri BA, Sanyal AJ. Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study. Hepatology Communications. 5: 938-946. PMID 34141981 DOI: 10.1002/hep4.1689 |
0.31 |
|
| 2021 |
Sekkarie A, Welsh JA, Northstone K, Stein AD, Ramakrishnan U, Vos MB. Associations between Free Sugar and Sugary Beverage Intake in Early Childhood and Adult NAFLD in a Population-Based UK Cohort. Children (Basel, Switzerland). 8. PMID 33917875 DOI: 10.3390/children8040290 |
0.6 |
|
| 2021 |
Cohen CC, Sekkarie A, Figueroa J, Gillespie SE, Vos MB, Welsh JA. Longitudinal associations of total and trunk fat in childhood and adolescence and risk of hepatic steatosis at 24 years. Pediatric Obesity. e12773. PMID 33559403 DOI: 10.1111/ijpo.12773 |
0.648 |
|
| 2020 |
Castillo-Leon E, Cioffi CE, Vos MB. Perspectives on youth-onset nonalcoholic fatty liver disease. Endocrinology, Diabetes & Metabolism. 3: e00184. PMID 33102800 DOI: 10.1002/edm2.184 |
0.382 |
|
| 2020 |
Sekkarie A, Welsh JA, Northstone K, Cioffi CE, Stein AD, Figueroa J, Ramakrishnan U, Vos MB. ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study. Children (Basel, Switzerland). 7. PMID 32882815 DOI: 10.3390/Children7090117 |
0.623 |
|
| 2020 |
Stratakis N, Conti DV, Jin R, Margetaki K, Valvi D, Siskos AP, Maitre L, Garcia E, Varo N, Zhao Y, Roumeliotaki T, Vafeiadi M, Urquiza J, Fernández-Barrés S, Heude B, ... ... Vos MB, et al. Prenatal Exposure to Perfluoroalkyl Substances Associated with Increased Susceptibility to Liver Injury in Children. Hepatology (Baltimore, Md.). PMID 32738061 DOI: 10.1002/Hep.31483 |
0.368 |
|
| 2020 |
Xanthakos SA, Lavine JE, Yates KP, Schwimmer JB, Molleston JP, Rosenthal P, Murray KF, Vos MB, Jain AK, Scheimann AO, Miloh T, Fishbein M, Behling CA, Brunt EM, Sanyal AJ, et al. Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. Gastroenterology. PMID 32712103 DOI: 10.1053/J.Gastro.2020.07.034 |
0.502 |
|
| 2020 |
Cioffi CE, Narayan KMV, Liu K, Uppal K, Jones DP, Tran V, Yu T, Alvarez JA, Bellissimo MP, Maner-Smith KM, Pierpoint B, Caprio S, Santoro N, Vos MB. Hepatic fat is a stronger correlate of key clinical and molecular abnormalities than visceral and abdominal subcutaneous fat in youth. Bmj Open Diabetes Research & Care. 8. PMID 32699106 DOI: 10.1136/Bmjdrc-2019-001126 |
0.409 |
|
| 2020 |
Roy M, Wang F, Vo H, Teng D, Teodoro G, Farris AB, Castillo-Lion E, Vos MB, Kong J. Deep-learning-based accurate hepatic steatosis quantification for histological assessment of liver biopsies. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 32661341 DOI: 10.1038/S41374-020-0463-Y |
0.375 |
|
| 2020 |
Sekkarie A, He S, Welsh JA, Ramakrishnan U, Stein AD, Vos MB. Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life. Annals of Hepatology. PMID 32507551 DOI: 10.1016/J.Aohep.2020.04.004 |
0.631 |
|
| 2020 |
Newton KP, Lavine JE, Wilson L, Behling C, Vos MB, Molleston JP, Rosenthal P, Miloh T, Fishbein MH, Jain AK, Murray KF, Schwimmer JB. Alanine Aminotransferase and Gamma Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.). PMID 32416645 DOI: 10.1002/Hep.31317 |
0.421 |
|
| 2020 |
Castillo-Leon E, Connelly MA, Konomi JV, Caltharp S, Cleeton R, Vos MB. Increased atherogenic lipoprotein profile in children with non-alcoholic steatohepatitis. Pediatric Obesity. e12648. PMID 32367624 DOI: 10.1111/Ijpo.12648 |
0.416 |
|
| 2020 |
Cusi K, Roden M, Barritt AS, Firpi RJ, Clark V, Klein S, Lok A, Newsome P, Corbin K, Vos MB, Reddy R, Schoen C, Mospan AR, Taunk JL, Wyne K, et al. 1472-P: Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus Diabetes. 69. DOI: 10.2337/Db20-1472-P |
0.382 |
|
| 2020 |
Sekkarie A, Figueroa J, Northstone K, Welsh J, Vos M. ALT Trends Through Childhood and Adolescence and Association with Hepatic Steatosis at 24 Years Current Developments in Nutrition. 4: 1686-1686. DOI: 10.1093/cdn/nzaa063_084 |
0.562 |
|
| 2019 |
Cioffi CE, Welsh JA, Alvarez JA, Hartman TJ, Narayan KMV, Vos MB. Associations of Added Sugar from All Sources and Sugar-Sweetened Beverages with Regional Fat Deposition in US Adolescents: NHANES 1999-2006. Current Developments in Nutrition. 3: nzz130. PMID 32154500 DOI: 10.1093/cdn/nzz130 |
0.554 |
|
| 2019 |
Jin R, McConnell R, Catherine C, Xu S, Walker DI, Stratakis N, Jones DP, Miller GW, Peng C, Conti DV, Vos MB, Chatzi L. Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach. Environment International. 105220. PMID 31744629 DOI: 10.1016/J.Envint.2019.105220 |
0.47 |
|
| 2019 |
Bellissimo MP, Cai Q, Ziegler TR, Liu KH, Tran PH, Vos MB, Martin GS, Jones DP, Yu T, Alvarez JA. Plasma High-Resolution Metabolomics Differentiates Adults with Normal Weight Obesity from Lean Individuals. Obesity (Silver Spring, Md.). 27: 1729-1737. PMID 31689010 DOI: 10.1002/Oby.22654 |
0.315 |
|
| 2019 |
Tylavsky FA, Ferrara A, Catellier DJ, Oken E, Li X, Law A, Dabelea D, Rundle A, Gilbert-Diamond D, Hivert MF, Breton CV, Cassidy-Bushrow AE, Mueller NT, Hunt KJ, Arteaga SS, ... ... Vos M, et al. Understanding childhood obesity in the US: the NIH environmental influences on child health outcomes (ECHO) program. International Journal of Obesity (2005). PMID 31649277 DOI: 10.1038/S41366-019-0470-5 |
0.31 |
|
| 2019 |
Cleveland ER, Ning H, Vos MB, Lewis CE, Rinella ME, Carr JJ, Lloyd-Jones DM, VanWagner LB. Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA Study. Journal of General Internal Medicine. PMID 31595464 DOI: 10.1007/S11606-019-05340-9 |
0.483 |
|
| 2019 |
Khusial RD, Cioffi CE, Caltharp SA, Krasinskas AM, Alazraki A, Knight-Scott J, Cleeton R, Castillo-Leon E, Jones DP, Pierpont B, Caprio S, Santoro N, Akil A, Vos MB. Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics. Hepatology Communications. 3: 1311-1321. PMID 31592078 DOI: 10.1002/hep4.1417 |
0.301 |
|
| 2019 |
Vos MB, Dimick-Santos L, Mehta R, Omokaro SO, Taminiau J, Schabel E, Kleiner DE, Szitanyi P, Socha P, Schwimmer JB, Noviello S, Silberg DG, Torstenson R, Miller V, Lavine JE. Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease. Gastroenterology. PMID 31520612 DOI: 10.1053/J.Gastro.2019.08.048 |
0.429 |
|
| 2019 |
Schwimmer JB, Ugalde-Nicalo P, Vos MB. Low Free Sugar Diet in Adolescents With Nonalcoholic Fatty Liver Disease-Reply. Jama. 321: 2469. PMID 31237636 DOI: 10.1001/Jama.2019.5153 |
0.488 |
|
| 2019 |
Cioffi CE, Alvarez JA, Welsh JA, Vos MB. Truncal-to-leg fat ratio and cardiometabolic disease risk factors in US adolescents: NHANES 2003-2006. Pediatric Obesity. e12509. PMID 30682733 DOI: 10.1111/Ijpo.12509 |
0.584 |
|
| 2019 |
Schwimmer JB, Ugalde-Nicalo P, Welsh JA, Angeles JE, Cordero M, Harlow KE, Alazraki A, Durelle J, Knight-Scott J, Newton KP, Cleeton R, Knott C, Konomi J, Middleton MS, Travers C, ... ... Vos MB, et al. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial. Jama. 321: 256-265. PMID 30667502 DOI: 10.1001/Jama.2018.20579 |
0.669 |
|
| 2019 |
CIOFFI CE, VENKAT NARAYAN K, UPPAL K, PIERPONT B, CAPRIO S, SANTORO N, VOS MB. 128-OR: Clustering of Metabolomics, Clinical Biomarkers, and Ectopic Liver Fat in Children/Adolescents: An Integrated Network Analysis Diabetes. 68: 128-OR. DOI: 10.2337/Db19-128-Or |
0.427 |
|
| 2018 |
Braun HA, Faasse SA, Vos MB. Advances in Pediatric Fatty Liver Disease: Pathogenesis, Diagnosis, and Treatment. Gastroenterology Clinics of North America. 47: 949-968. PMID 30337043 DOI: 10.1016/J.Gtc.2018.07.016 |
0.482 |
|
| 2018 |
Younossi Z, Tacke F, Arrese M, Sharma BC, Mostafa I, Bugianesi E, Wong VW, Yilmaz Y, George J, Fan J, Vos MB. Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Hepatology (Baltimore, Md.). PMID 30179269 DOI: 10.1002/Hep.30251 |
0.482 |
|
| 2018 |
Vos MB, Jin R, Konomi JV, Cleeton R, Cruz J, Karpen S, Rodriguez DS, Frediani JK, McCracken C, Welsh J. A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease. Pilot and Feasibility Studies. 4: 109. PMID 29992039 DOI: 10.1186/S40814-018-0306-4 |
0.67 |
|
| 2018 |
Arsik I, Frediani JK, Frezza D, Chen W, Ayer T, Keskinocak P, Jin R, Konomi JV, Barlow SE, Xanthakos SA, Lavine JE, Vos MB. Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data. Children (Basel, Switzerland). 5. PMID 29799476 DOI: 10.3390/Children5060064 |
0.477 |
|
| 2018 |
Sekkarie A, Welsh JA, Vos MB. Carbohydrates and diet patterns in nonalcoholic fatty liver disease in children and adolescents. Current Opinion in Clinical Nutrition and Metabolic Care. PMID 29781841 DOI: 10.1097/Mco.0000000000000476 |
0.681 |
|
| 2018 |
Harlow KE, Africa JA, Wells A, Belt PH, Behling CA, Jain AK, Molleston JP, Newton KP, Rosenthal P, Vos MB, Xanthakos SA, Lavine JE, Schwimmer JB. Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease. The Journal of Pediatrics. PMID 29661561 DOI: 10.1016/J.Jpeds.2018.02.038 |
0.355 |
|
| 2018 |
Van Wagner LB, Ning H, Allen NB, Siddique J, Carson AP, Bancks MP, Lewis CE, Carr JJ, Speliotes E, Terrault NA, Rinella ME, Vos MB, Lloyd-Jones DM. 25-Year Trajectories of Insulin Resistance and Pancreatic β-Cell Response and Diabetes Risk in Nonalcoholic Fatty Liver Disease. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 29608255 DOI: 10.1111/Liv.13747 |
0.401 |
|
| 2018 |
Li H, Byers HM, Diaz-Kuan A, Vos MB, Hall PL, Tortorelli S, Singh R, Wallenstein MB, Allain M, Dimmock DP, Farrell RM, McCandless S, Gambello MJ. Acute liver failure in neonates with undiagnosed hereditary fructose intolerance due to exposure from widely available infant formulas. Molecular Genetics and Metabolism. PMID 29510902 DOI: 10.1016/J.Ymgme.2018.02.016 |
0.336 |
|
| 2018 |
Faasse S, Braun H, Vos M. The role of NAFLD in cardiometabolic disease: an update. F1000research. 7: 170. PMID 29497497 DOI: 10.12688/f1000research.12028.1 |
0.373 |
|
| 2018 |
Frediani JK, Naioti EA, Vos MB, Figueroa J, Marsit CJ, Welsh JA. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014. Environmental Health : a Global Access Science Source. 17: 6. PMID 29334960 DOI: 10.1186/S12940-017-0350-1 |
0.675 |
|
| 2018 |
Jin R, Vos M, Walker DI, Cioffi C, Santoro N, Jones D, McConnell R, Chatzi L. Perfluoroalkyl Substances (PFASs) and Liver Inflammation and Fibrosis in Children with Nonalcoholic Fatty Liver Disease (NAFLD) Isee Conference Abstracts. 2018. DOI: 10.1289/isesisee.2018.o04.02.37 |
0.396 |
|
| 2018 |
Palle S, Bilhartz JL, Lavine JE, Malahias L, Miloh T, Rudolph B, Schoen C, Xanthakos S, McKiernan P, Vos MB. Mo1495 - Nonalcoholic Liver Disease in Children in the US: Clinical Characteristics of Participants Enrolled in Target-NASH Gastroenterology. 154: S-1217-S-1218. DOI: 10.1016/S0016-5085(18)34022-8 |
0.429 |
|
| 2018 |
Doan S, Niklinska-Schirtz BJ, Vos MB. Update on Pediatric Fatty Liver Disease Current Hepatology Reports. 17: 361-366. DOI: 10.1007/S11901-018-0427-5 |
0.496 |
|
| 2017 |
Song M, Li X, Zhang X, Shi H, Vos MB, Wei X, Wang Y, Gao H, Rouchka EC, Yin X, Zhou Z, Prough RA, Cave MC, McClain CJ. Dietary Copper-Fructose Interactions Alter Gut Microbial Activity in Male Rats. American Journal of Physiology. Gastrointestinal and Liver Physiology. ajpgi.00378.2016. PMID 29025734 DOI: 10.1152/Ajpgi.00378.2016 |
0.372 |
|
| 2017 |
VanWagner LB, Khan SS, Ning H, Siddique J, Lewis CE, Carr JJ, Vos MB, Speliotes E, Terrault NA, Rinella ME, Lloyd-Jones DM, Allen NB. Body Mass Index Trajectories in Young Adulthood Predict Nonalcoholic Fatty Liver Disease in Middle Age: The CARDIA Cohort Study. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 28963767 DOI: 10.1111/Liv.13603 |
0.451 |
|
| 2017 |
Jackson JA, Konomi JV, Mendoza MV, Krasinskas A, Jin R, Caltharp S, Mouzaki M, Vos MB. Performance of fibrosis prediction scores in paediatric non-alcoholic fatty liver disease. Journal of Paediatrics and Child Health. PMID 28948665 DOI: 10.1111/Jpc.13689 |
0.474 |
|
| 2017 |
Vos MB, Goran MI. Sugar, Sugar . . . Not So Sweet for the Liver. Gastroenterology. PMID 28757270 DOI: 10.1053/J.Gastro.2017.07.029 |
0.424 |
|
| 2017 |
Sidney Barritt A, Gitlin N, Klein S, Lok AS, Loomba R, Malahias L, Powell M, Vos MB, Michael Weiss L, Cusi K, Neuschwander-Tetri BA, Sanyal A. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. Contemporary Clinical Trials. PMID 28735109 DOI: 10.1016/J.Cct.2017.07.015 |
0.442 |
|
| 2017 |
He S, Le NA, Frediani JK, Winterberg PD, Jin R, Liverman R, Hernandez A, Cleeton RL, Vos MB. Cardiometabolic risks vary by weight status in pediatric kidney and liver transplant recipients: A cross-sectional, single-center study in the USA. Pediatric Transplantation. PMID 28718192 DOI: 10.1111/Petr.12984 |
0.367 |
|
| 2017 |
Mendoza M, Caltharp S, Song M, Collin L, Konomi JV, McClain CJ, Vos MB. Low Hepatic Tissue Copper in Pediatric Nonalcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition. 65: 89-92. PMID 28644356 DOI: 10.1097/Mpg.0000000000001571 |
0.482 |
|
| 2017 |
Cioffi CE, Welsh JA, Cleeton RL, Caltharp SA, Romero R, Wulkan ML, Konomi JV, Frediani JK, Vos MB. Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study. Children (Basel, Switzerland). 4. PMID 28467377 DOI: 10.3390/Children4050034 |
0.582 |
|
| 2017 |
Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, ... ... Vos MB, et al. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration. Hepatology (Baltimore, Md.). PMID 28390159 DOI: 10.1002/Hep.29204 |
0.326 |
|
| 2017 |
Mendoza M, Caltharp S, Song M, Collin L, Konomi JV, McClain CJ, Vos MB. Low Hepatic Tissue Copper in Pediatric Non-Alcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition. PMID 28319602 DOI: 10.1097/MPG.0000000000001571 |
0.377 |
|
| 2017 |
Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, Mouzaki M, Sathya P, Schwimmer JB, Sundaram SS, Xanthakos SA. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). Journal of Pediatric Gastroenterology and Nutrition. 64: 319-334. PMID 28107283 DOI: 10.1097/Mpg.0000000000001482 |
0.399 |
|
| 2017 |
VanWagner LB, Bancks M, Ning H, Siddique J, Lewis C, Jeffrey Carr J, Vos M, Speliotes E, Terrault N, Rinella ME, Allen NB, Lloyd-Jones D. 2111 Journal of Clinical and Translational Science. 1: 23-24. DOI: 10.1017/cts.2017.94 |
0.344 |
|
| 2017 |
Bazerbachi F, Furuya K, Abdou R, Alqoaer K, Amin M, Amir A, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Gottrand M, ... ... Vos M, et al. Recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium Journal of Hepatology. 66: S76. DOI: 10.1016/S0168-8278(17)30414-2 |
0.382 |
|
| 2017 |
Song M, Zhang X, Wang Y, Vos MB, Prough R, Cave MC, McClain CJ. Endotoxemia is not Required for Dietary Copper-Fructose Interactions Induced Hepatic Steatosis in Male Rats Gastroenterology. 152: S1117. DOI: 10.1016/S0016-5085(17)33765-4 |
0.304 |
|
| 2017 |
Bazerbachi F, Furuya K, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, Gottrand M, ... ... Vos MB, et al. Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation in Children: Data from the Pediatric PSC Consortium Gastroenterology. 152: S1063-S1064. DOI: 10.1016/S0016-5085(17)33590-4 |
0.382 |
|
| 2017 |
Ricciuto A, Kamath BM, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Matary W, El-Youssef M, Ferrari F, ... ... Vos MB, et al. A Comparison of Primary Sclerosing Cholangitis with and Without Associated Inflammatory Bowel Disease: Data from the Pediatric PSC Consortium Gastroenterology. 152: S1057. DOI: 10.1016/S0016-5085(17)33571-0 |
0.322 |
|
| 2017 |
Jin R, Frediani JK, Holzberg J, Vos MB. Role of PAI-1 in Pediatric Obesity and Nonalcoholic Fatty Liver Disease Current Cardiovascular Risk Reports. 11. DOI: 10.1007/S12170-017-0536-7 |
0.468 |
|
| 2016 |
Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, Mouzaki M, Sathya P, Schwimmer JB, Sundaram SS, Xanthakos SA. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children. Journal of Pediatric Gastroenterology and Nutrition. PMID 27906803 DOI: 10.1097/MPG.0000000000001482 |
0.396 |
|
| 2016 |
Jin R, Krasinskas A, Le NA, Konomi JV, Holzberg J, Romero R, Vos MB. Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease. Pediatric Obesity. PMID 27764892 DOI: 10.1111/ijpo.12183 |
0.39 |
|
| 2016 |
Schwimmer JB, Lavine JE, Wilson LA, Neuschwander-Tetri BA, Xanthakos SA, Kohli R, Barlow SE, Vos MB, Karpen SJ, Molleston JP, Whitington PF, Rosenthal P, Jain AK, Murray KF, Brunt EM, et al. In Children with Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but does not Reduce Disease Activity Scores. Gastroenterology. PMID 27569726 DOI: 10.1053/J.Gastro.2016.08.027 |
0.481 |
|
| 2016 |
Vos MB, Kaar JL, Welsh JA, Van Horn LV, Feig DI, Anderson CA, Patel MJ, Cruz Munos J, Krebs NF, Xanthakos SA, Johnson RK. Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association. Circulation. PMID 27550974 DOI: 10.1161/Cir.0000000000000439 |
0.621 |
|
| 2016 |
Jin R, Banton S, Tran VT, Konomi JV, Li S, Jones DP, Vos MB. Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study. The Journal of Pediatrics. PMID 26858195 DOI: 10.1016/J.Jpeds.2016.01.026 |
0.407 |
|
| 2016 |
Kohli R, Sunduram S, Mouzaki M, Ali S, Sathya P, Abrams S, Xanthakos SA, Vos M, Schwimmer JB. Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON). The Journal of Pediatrics. PMID 26749112 DOI: 10.1016/J.Jpeds.2015.12.016 |
0.544 |
|
| 2016 |
Vos M, Jin R, Welsh J, Konomi J, Karpen SJ, Soler-Rodriquez D, Cleeton RL, Jones D. 500 Losartan Improves Hepatic Inflammation in Children With Non-Alcoholic Fatty Liver Disease Gastroenterology. 150: S1036. DOI: 10.1016/S0016-5085(16)33501-6 |
0.657 |
|
| 2015 |
Jin R, Vos MB. Fructose and liver function--is this behind nonalcoholic liver disease? Current Opinion in Clinical Nutrition and Metabolic Care. 18: 490-5. PMID 26203597 DOI: 10.1097/Mco.0000000000000203 |
0.472 |
|
| 2015 |
Jin R, Le NA, Cleeton R, Sun X, Cruz Muños J, Otvos J, Vos MB. Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents. Lipids in Health and Disease. 14: 39. PMID 25925168 DOI: 10.1186/s12944-015-0038-x |
0.43 |
|
| 2015 |
Corey KE, Vuppalanchi R, Vos M, Kohli R, Molleston JP, Wilson L, Unalp-Arida A, Cummings OW, Lavine JE, Chalasani N. Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition. 60: 360-7. PMID 25714579 DOI: 10.1097/Mpg.0000000000000584 |
0.515 |
|
| 2015 |
Nelson JM, Vos MB, Walsh SM, O'Brien LA, Welsh JA. Weight management-related assessment and counseling by primary care providers in an area of high childhood obesity prevalence: current practices and areas of opportunity. Childhood Obesity (Print). 11: 194-201. PMID 25585234 DOI: 10.1089/Chi.2014.0052 |
0.559 |
|
| 2015 |
Welsh JA, Nelson JM, Walsh S, Sealer H, Palmer W, Vos MB. Brief training in patient-centered counseling for healthy weight management increases counseling self-efficacy and goal setting among pediatric primary care providers: results of a pilot program. Clinical Pediatrics. 54: 425-9. PMID 25336443 DOI: 10.1177/0009922814553432 |
0.516 |
|
| 2014 |
Walsh SM, Palmer W, Welsh JA, Vos MB. Challenges and successes of a multidisciplinary pediatric obesity treatment program Nutrition in Clinical Practice. 29: 780-785. PMID 25335786 DOI: 10.1177/0884533614551839 |
0.535 |
|
| 2014 |
Jin R, Willment A, Patel SS, Sun X, Song M, Mannery YO, Kosters A, McClain CJ, Vos MB. Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease. International Journal of Hepatology. 2014: 560620. PMID 25328713 DOI: 10.1155/2014/560620 |
0.468 |
|
| 2014 |
Jin R, Welsh JA, Le NA, Holzberg J, Sharma P, Martin DR, Vos MB. Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients. 6: 3187-201. PMID 25111123 DOI: 10.3390/Nu6083187 |
0.674 |
|
| 2014 |
Lee AK, Binongo JN, Chowdhury R, Stein AD, Gazmararian JA, Vos MB, Welsh JA. Consumption of less than 10% of total energy from added sugars is associated with increasing HDL in females during adolescence: a longitudinal analysis. Journal of the American Heart Association. 3: e000615. PMID 24572253 DOI: 10.1161/Jaha.113.000615 |
0.567 |
|
| 2014 |
Vos MB. Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field. Current Opinion in Lipidology. 25: 61-6. PMID 24366230 DOI: 10.1097/Mol.0000000000000043 |
0.483 |
|
| 2014 |
Whitington PF, Vos MB, Bass LM, Melin-Aldana H, Romero R, Roy CC, Alvarez F. Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia. Journal of Pediatric Gastroenterology and Nutrition. 58: 74-80. PMID 23969541 DOI: 10.1097/Mpg.0B013E3182A98Dbe |
0.372 |
|
| 2014 |
Vos MB. NAFLD in the transition from adolescence to young adulthood Clinical Liver Disease. 4: 93-95. DOI: 10.1002/cld.422 |
0.322 |
|
| 2013 |
St-Jules DE, Watters CA, Brunt EM, Wilkens LR, Novotny R, Belt P, Lavine JE, Abrams SH, Himes R, Krisnamurthy R, Maldonado L, Morris B, Bernstein K, Cecil K, DeVore S, ... ... Vos M, et al. Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease Journal of Pediatric Gastroenterology and Nutrition. 57: 627-633. PMID 24177784 DOI: 10.1097/Mpg.0B013E3182A1Df77 |
0.473 |
|
| 2013 |
Sylvetsky AC, Hennink M, Comeau D, Welsh JA, Hardy T, Matzigkeit L, Swan DW, Walsh SM, Vos MB. Youth understanding of healthy eating and obesity: a focus group study. Journal of Obesity. 2013: 670295. PMID 23956844 DOI: 10.1155/2013/670295 |
0.529 |
|
| 2013 |
Lee MJ, Bagci P, Kong J, Vos MB, Sharma P, Kalb B, Saltz JH, Martin DR, Adsay NV, Farris AB. Liver steatosis assessment: correlations among pathology, radiology, clinical data and automated image analysis software. Pathology, Research and Practice. 209: 371-9. PMID 23707550 DOI: 10.1016/J.Prp.2013.04.001 |
0.344 |
|
| 2013 |
Song M, Schuschke DA, Zhou Z, Chen T, Shi X, Zhang J, Zhang X, Pierce WM, Johnson WT, Vos MB, McClain CJ. Modest fructose beverage intake causes liver injury and fat accumulation in marginal copper deficient rats. Obesity (Silver Spring, Md.). 21: 1669-75. PMID 23512597 DOI: 10.1002/Oby.20380 |
0.425 |
|
| 2013 |
Vos MB. Furthering the understanding of maternal obesity in nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). 58: 4-5. PMID 23504746 DOI: 10.1002/Hep.26389 |
0.528 |
|
| 2013 |
Vos MB, Lavine JE. Dietary fructose in nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). 57: 2525-31. PMID 23390127 DOI: 10.1002/Hep.26299 |
0.52 |
|
| 2013 |
Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. The Journal of Pediatrics. 162: 496-500.e1. PMID 23084707 DOI: 10.1016/J.Jpeds.2012.08.043 |
0.663 |
|
| 2013 |
Lin HC, Kahana D, Vos MB, Black D, Port Z, Shulman R, Scheimann A, Mascarenhas MR. Assessment of nutrition education among pediatric gastroenterologists: a survey of NASPGHAN members. Journal of Pediatric Gastroenterology and Nutrition. 56: 137-44. PMID 22699840 DOI: 10.1097/Mpg.0B013E3182638Ce8 |
0.307 |
|
| 2012 |
Sylvetsky AC, Welsh JA, Brown RJ, Vos MB. Low-calorie sweetener consumption is increasing in the United States. The American Journal of Clinical Nutrition. 96: 640-6. PMID 22854409 DOI: 10.3945/Ajcn.112.034751 |
0.555 |
|
| 2012 |
Jin R, Le NA, Liu S, Farkas Epperson M, Ziegler TR, Welsh JA, Jones DP, McClain CJ, Vos MB. Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. The Journal of Clinical Endocrinology and Metabolism. 97: E1088-98. PMID 22544914 DOI: 10.1210/Jc.2012-1370 |
0.595 |
|
| 2012 |
Vos MB, Colvin R, Belt P, Molleston JP, Murray KF, Rosenthal P, Schwimmer JB, Tonascia J, Unalp A, Lavine JE. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD Journal of Pediatric Gastroenterology and Nutrition. 54: 90-96. PMID 22197855 DOI: 10.1097/Mpg.0B013E318229Da1A |
0.494 |
|
| 2012 |
Vos M, Barlow SE. Update in childhood and adolescent obesity. Pediatric Clinics of North America. 58: xv-xvii. PMID 22093868 DOI: 10.1016/J.Pcl.2011.09.016 |
0.322 |
|
| 2012 |
Kamat P, Kunde S, Vos M, Vats A, Gupta N, Heffron T, Romero R, Fortenberry JD. Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 13: e33-8. PMID 21263362 DOI: 10.1097/Pcc.0B013E31820Ac08F |
0.382 |
|
| 2012 |
Bulut P, Romero R, McConnell M, Braithwaite K, Mahle W, Gupta NA, Vos MB, Alazraki A. 707 MRI Identifies Unsuspected Liver Dysfunction in Patients After Fontan Procedure Gastroenterology. 142: S-925-S-926. DOI: 10.1016/S0016-5085(12)63590-2 |
0.367 |
|
| 2012 |
Vos MB, Welsh J. 705 Prevalence of Suspected NAFLD is Increasing Among US Adolescents Gastroenterology. 142: S-925. DOI: 10.1016/S0016-5085(12)63588-4 |
0.593 |
|
| 2011 |
Mannery YO, McClain CJ, Vos MB. Keratin 18, Apoptosis, and Liver Disease in Children. Current Pediatric Reviews. 7: 310-315. PMID 25346653 DOI: 10.2174/157339611796892364 |
0.481 |
|
| 2011 |
Kunde SS, Roede JR, Vos MB, Orr ML, Go YM, Park Y, Ziegler TR, Jones DP. Hepatic oxidative stress in fructose-induced fatty liver is not caused by sulfur amino acid insufficiency. Nutrients. 3: 987-1002. PMID 22254090 DOI: 10.3390/Nu3110987 |
0.379 |
|
| 2011 |
Welsh JA, Sharma AJ, Grellinger L, Vos MB. Consumption of added sugars is decreasing in the United States. The American Journal of Clinical Nutrition. 94: 726-34. PMID 21753067 DOI: 10.3945/Ajcn.111.018366 |
0.535 |
|
| 2011 |
Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E. Pediatric liver transplantation for primary sclerosing cholangitis. Liver Transplantation. 17: 925-933. PMID 21506253 DOI: 10.1002/Lt.22320 |
0.388 |
|
| 2011 |
Welsh JA, Sharma A, Cunningham SA, Vos MB. Consumption of added sugars and indicators of cardiovascular disease risk among US adolescents. Circulation. 123: 249-57. PMID 21220734 DOI: 10.1161/Circulationaha.110.972166 |
0.604 |
|
| 2011 |
Welsh JA, Sharma AJ, Grellinger L, Vos MB. Reply to BP Marriott et al American Journal of Clinical Nutrition. 94: 1653. DOI: 10.3945/ajcn.111.026559 |
0.425 |
|
| 2011 |
Kamat P, Kunde S, Vos M, Vats A, Heffron T, Romero R, Fortenberry J. Invasive versus noninvasive intracranial pressure monitoring in children with acute liver failure Pediatric Critical Care Medicine. 12: 695-696. DOI: 10.1097/Pcc.0B013E31822882C7 |
0.351 |
|
| 2010 |
Vos MB, Welsh J. Childhood obesity: update on predisposing factors and prevention strategies. Current Gastroenterology Reports. 12: 280-7. PMID 20563673 DOI: 10.1007/S11894-010-0116-1 |
0.601 |
|
| 2010 |
Welsh JA, Sharma A, Abramson JL, Vaccarino V, Gillespie C, Vos MB. Caloric sweetener consumption and dyslipidemia among US adults. Jama. 303: 1490-7. PMID 20407058 DOI: 10.1001/Jama.2010.449 |
0.603 |
|
| 2010 |
Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annual Review of Pathology. 5: 145-71. PMID 20078219 DOI: 10.1146/Annurev-Pathol-121808-102132 |
0.498 |
|
| 2009 |
Vos MB, Weber MB, Welsh J, Khatoon F, Jones DP, Whitington PF, McClain CJ. Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic fatty liver disease: a pilot study. Archives of Pediatrics & Adolescent Medicine. 163: 674-5. PMID 19581556 DOI: 10.1001/Archpediatrics.2009.93 |
0.684 |
|
| 2008 |
Vos MB, Barve S, Joshi-Barve S, Carew JD, Whitington PF, McClain CJ. Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition. 47: 481-5. PMID 18852641 DOI: 10.1097/Mpg.0B013E31817E2Bfb |
0.508 |
|
| 2008 |
Vos MB, McClain CJ. Nutrition and nonalcoholic fatty liver disease in children. Current Diabetes Reports. 8: 399-406. PMID 18778590 DOI: 10.1007/s11892-008-0069-z |
0.435 |
|
| 2008 |
Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape Journal of Medicine. 10: 160. PMID 18769702 |
0.588 |
|
| 2008 |
Vos MB, McClain CJ. Nutrition and nonalcoholic fatty liver disease in children. Current Gastroenterology Reports. 10: 308-15. PMID 18625143 DOI: 10.1007/s11894-008-0061-4 |
0.435 |
|
| 2008 |
Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. Journal of Hepatology. 48: 983-992. PMID 18395289 DOI: 10.1016/J.Jhep.2008.01.035 |
0.394 |
|
| 2008 |
Vos M, Colvin R, Belt PH, Bryan D, Molleston JP, Murray KF, Rosenthal P, Schwimmer J, Tonascia J, Unalp A, Lavine JE. S1905 Lack of Correlation Between Diet Composition and Pediatric NAFLD Severity Gastroenterology. 134: A-781. DOI: 10.1016/S0016-5085(08)63647-1 |
0.338 |
|
| Show low-probability matches. |